Showing results (11-20 of 1,878) with videos related to
Sort By:
Pageof 188
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
Effect of tetrahydrocannabinols on 3H-acetylcholine biosynthesis in various rat brain slicesE Friedman, I Hanin, S GershonEuropean Journal of Pharmacology|March 7, 1977
Antidepressant drugs and dopamine uptake in different brain regionsE Friedman, F Fung, S GershonEuropean Journal of Pharmacology|April 1, 1975
Cardiovascular actions of 2,5-dimethoxy-4-methylamphetamine (DOM) in the catA S Tadepalli, E Friedman, S GershonArchives of General Psychiatry|September 1, 1980
Prostaglandins, platelets, and schizophreniaJ Rotrosen, A D Miller, D Mandio, et al.Psychopharmacology|January 1, 1979
Atypical antidopaminergic properties of CI-686: a potential antipsychotic agentM Stanley, J Rotrosen, N Sculerati, et al.Psychopharmacology|December 21, 1976
Dopamine receptor alteration in schizophrenia: neuroendocrine evidenceJ Rotrosen, B M Angrist, S Gershon, et al.Science (New York, N.Y.)|February 7, 1975
Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinolB Hine, E Friedman, M Torrelio, et al.British Journal of Pharmacology|April 1, 1977
Cardiovascular effects of delta9-tetrahydrocannabinol in conscious and anaesthetized dogsE Friedman, S Gershon, B Hine, et al.Journal of Neural Transmission|January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidolB Angrist, M Ain, J Rotrosen, et al.The American Journal of Psychiatry|August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controlsJ Rotrosen, B Angrist, C Clark, et al.Pageof 188